In a significant leap for regenerative medicine and hematology, researchers at the University of Basel and University Hospital Basel have…
Read More
Ludwig Cancer Research Unveils Synergistic Combination Therapy Targeting Differentiation Blockade in Acute Myelogenous Leukemia
The landscape of hematological oncology is facing a potential paradigm shift following a landmark study by Ludwig Cancer Research, which…
Read More
AI-Powered "GPS" Model Marks Paradigm Shift in Drug Discovery, Identifies Candidates for Liver Cancer and Pulmonary Fibrosis
A groundbreaking machine-learning model, dubbed "GPS" (Gene Expression Profile Predictor on Chemical Structures), has been unveiled by a multi-institute collaboration…
Read More
Clinical Labs May Gain New Edge in Early Cancer Detection with Epigenetic Instability Liquid Biopsy
This groundbreaking research from the Johns Hopkins Kimmel Cancer Center marks a significant stride in the quest for more effective…
Read More
Roche and C4 Therapeutics Forge Strategic Alliance to Pioneer Degrader-Antibody Conjugates for Novel Cancer Therapies
Roche and C4 Therapeutics Forge Strategic Alliance to Pioneer Degrader-Antibody Conjugates for Novel Cancer Therapies Roche, a global pharmaceutical giant,…
Read More
Johns Hopkins Researchers Discover How Gene Fusion Droplets Drive Rare Kidney Cancer Progression
In a landmark study published in the journal Cell Reports on April 22, investigators at the Johns Hopkins Kimmel Cancer…
Read More
Deciphering the Distinct Roles of BET Proteins: A New Paradigm for Targeted Cancer Therapy Emerges from Max Planck Research
The global fight against cancer, a disease projected to claim over 10 million lives annually, continues to drive intense research…
Read More
Snail-Inspired Soft Robots Poised to Revolutionize Precision Drug Delivery for Cancer and Beyond
Inspired by the remarkable locomotion of gastropods, a pioneering drug delivery project led by the University of Manchester has secured…
Read More
European Commission Approves Keytruda Combination Therapy for PD-L1-Positive Platinum-Resistant Ovarian Cancer
The European Commission (EC) has granted approval for Keytruda (pembrolizumab) in combination with paclitaxel, with or without bevacizumab, as a…
Read More
Houston Methodist Researchers Identify TDP43 Protein as a Primary Regulator of DNA Mismatch Repair Linking Neurodegeneration and Cancer
In a landmark study that bridges the traditionally separate fields of neurology and oncology, researchers at the Houston Methodist Research…
Read More
